An open-label comparison of the immunogenicity and tolerability of intranasal and intramuscular formulations of virosomal influenza vaccine in healthy adults

This publication has 23 references indexed in Scilit:

• Vaccines for Mucosal Immunity to Combat Emerging Infectious Diseases
  Emerging Infectious Diseases, 2000
• Correlates of Immune Protection Induced by Live, Attenuated, Cold‐Adapted, Trivalent, Intranasal Influenza Virus Vaccine
  The Journal of Infectious Diseases, 2000
• Influenza
  The Lancet, 1999
• Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients
  Vaccine, 1997
• Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin
  Vaccine, 1996
• Mucosal immune responses to pneumococcal polysaccharides: implications for vaccination
  Trends in Microbiology, 1995
• Immunogenicity of new virosome influenza vaccine in elderly people
  The Lancet, 1994
• New strategies for using mucosal vaccination to achieve more effective immunization
  Vaccine, 1994
• Immunogenicity of trivalent subunit and split influenza vaccines (1989–90 winter season) in volunteers of different groups of age
  Vaccine, 1991
• Liposomes as immunological adjuvants
  Nature, 1974